den Dunnen JT - Search Results

1

The effects of low levels of dystrophin on mouse muscle function and pathology.

van Putten M, Hulsker M, Nadarajah VD, van Heiningen SH, van Huizen E, van Iterson M, Admiraal P, Messemaker T, den Dunnen JT, 't Hoen PA, Aartsma-Rus A. van Putten M, et al. Among authors: den dunnen jt. PLoS One. 2012;7(2):e31937. doi: 10.1371/journal.pone.0031937. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359642 Free PMC article.

2

Mapping of dystrophin brain promoter: a deletion of this region is compatible with normal intellect.

den Dunnen JT, Casula L, Makover A, Bakker B, Yaffe D, Nudel U, van Ommen GJ. den Dunnen JT, et al. Neuromuscul Disord. 1991;1(5):327-31. doi: 10.1016/0960-8966(91)90118-c. Neuromuscul Disord. 1991. PMID: 1822342

3

Detection of truncated dystrophin in fetal DMD myotubes.

Ginjaar IB, Bakker E, den Dunnen JT, Wessels A, van Paassen MM, Kloosterman MD, Zubrzycka-Gaarn EE, Fischbeck KH, Moorman AF, van Ommen GJ. Ginjaar IB, et al. Among authors: den dunnen jt. Adv Exp Med Biol. 1990;280:17-23. doi: 10.1007/978-1-4684-5865-7_4. Adv Exp Med Biol. 1990. PMID: 2248137

4

Expression of the human Dp 71 (apo-dystrophin-1) gene from a 760-kb DMD-YAC transferred to mouse cells.

Heikoop JC, Hogervorst FB, Meershoek EJ, Grootscholten PM, den Dunnen JT, van Ommen GJ. Heikoop JC, et al. Among authors: den dunnen jt. Eur J Hum Genet. 1995;3(3):168-79. doi: 10.1159/000472292. Eur J Hum Genet. 1995. PMID: 7583042

5

Point mutation screening for 16 exons of the dystrophin gene by multiplex single-strand conformation polymorphism analysis.

Kneppers AL, Deutz-Terlouw PP, den Dunnen JT, van Ommen GJ, Bakker E. Kneppers AL, et al. Among authors: den dunnen jt. Hum Mutat. 1995;5(3):235-42. doi: 10.1002/humu.1380050308. Hum Mutat. 1995. PMID: 7599634

6

Application of in vitro Myo-differentiation of non-muscle cells to enhance gene expression and facilitate analysis of muscle proteins.

Roest PA, van der Tuijn AC, Ginjaar HB, Hoeben RC, Hoger-Vorst FB, Bakker E, den Dunnen JT, van Ommen GJ. Roest PA, et al. Among authors: den dunnen jt. Neuromuscul Disord. 1996 May;6(3):195-202. doi: 10.1016/0960-8966(96)00006-5. Neuromuscul Disord. 1996. PMID: 8784808

7

Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family.

Ginjaar IB, Kneppers AL, v d Meulen JD, Anderson LV, Bremmer-Bout M, van Deutekom JC, Weegenaar J, den Dunnen JT, Bakker E. Ginjaar IB, et al. Among authors: den dunnen jt. Eur J Hum Genet. 2000 Oct;8(10):793-6. doi: 10.1038/sj.ejhg.5200535. Eur J Hum Genet. 2000. PMID: 11039581

8

Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.

van Deutekom JC, Bremmer-Bout M, Janson AA, Ginjaar IB, Baas F, den Dunnen JT, van Ommen GJ. van Deutekom JC, et al. Among authors: den dunnen jt. Hum Mol Genet. 2001 Jul 15;10(15):1547-54. doi: 10.1093/hmg/10.15.1547. Hum Mol Genet. 2001. PMID: 11468272

9

[From gene to disease; the dystrophin gene involved in Duchenne and Becker muscular dystrophy].

den Dunnen JT, de Visser M, Bakker E. den Dunnen JT, et al. Ned Tijdschr Geneeskd. 2002 Feb 23;146(8):364-7. Ned Tijdschr Geneeskd. 2002. PMID: 11887623 Review. Dutch.

10

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy.

Aartsma-Rus A, Bremmer-Bout M, Janson AA, den Dunnen JT, van Ommen GJ, van Deutekom JC. Aartsma-Rus A, et al. Among authors: den dunnen jt. Neuromuscul Disord. 2002 Oct;12 Suppl 1:S71-7. doi: 10.1016/s0960-8966(02)00086-x. Neuromuscul Disord. 2002. PMID: 12206800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters